- ICH GCP
- US Clinical Trials Registry
- Search trials
Kliniske forsøg sponsoreret af Zhejiang Hospital
I alt 101151 resultater
-
Zhejiang Cancer HospitalUkendt
-
Zhejiang Cancer HospitalAfsluttetIkke-småcellet lungekræft
-
Zhejiang Cancer HospitalUkendt
-
Zhejiang Cancer HospitalUkendtEsophageal pladecellekarcinomKina
-
Zhejiang Cancer HospitalUkendtCarcinom, hepatocellulærtKina
-
Zhejiang Cancer HospitalUkendtBrystkræft | Lymfeknudemetastaser | Prædiktiv kræftmodelKina
-
Zhejiang Cancer HospitalUkendt
-
Zhejiang Cancer HospitalUkendt
-
Zhejiang Cancer HospitalUkendtNasopharyngeale neoplasmer | StomatitisKina
-
Zhejiang Cancer HospitalUkendt
-
Zhejiang Cancer HospitalUkendt
-
Zhejiang Cancer HospitalUkendtIkke-småcellet lungekræft | Erhvervet modstand | EGFR TKI'erKina
-
Zhejiang Cancer HospitalUkendtMetastatisk brystkræftKina
-
Zhejiang Cancer HospitalUkendtIkke-småcellet lungekræftKina
-
Zhejiang Cancer HospitalAfsluttetLungekræft | Metastatisk kræftKina
-
Zhejiang Cancer HospitalUkendtLokalt avanceret endetarmskræftKina
-
Zhejiang Cancer HospitalUkendtEsophageal Squamous Cell Carcinoma ResectableKina
-
Zhejiang Cancer HospitalUkendtIkke-småcellet lungekræft | HjernemetastaserKina
-
Zhejiang Cancer HospitalUkendt
-
Zhejiang Cancer HospitalRekrutteringLokalt avanceret inoperabelt esophagealt planocellulært karcinomKina
-
Zhejiang Cancer HospitalIkke rekrutterer endnu
-
Zhejiang Cancer HospitalRekrutteringIkke-resekterbart pancreascarcinomKina
-
Zhejiang Cancer HospitalRekrutteringHER2 genmutation | Galdevejsadenokarcinom Ikke-resekterbartKina
-
Zhejiang Cancer HospitalIkke rekrutterer endnuNasopharyngealt karcinom
-
Zhejiang Cancer HospitalRekrutteringMavekræft | Kolorektal cancer | Adenocarcinom i bugspytkirtlen | Galdevejskræft | Gastroøsofageal Junction Adenocarcinom | Leverkræft Stadium IVKina
-
Zhejiang Cancer HospitalRekrutteringKardiotoksicitet induceret af lægemiddelterapi for brystkræftKina
-
Zhejiang Cancer HospitalRekrutteringLeverkræft | CiprofolKina
-
Zhejiang Cancer HospitalIkke rekrutterer endnuIkke-småcellet lungekræft stadie III
-
Zhejiang Cancer HospitalIkke rekrutterer endnuAvanceret tyktarmskræftKina
-
Zhejiang Cancer HospitalIkke rekrutterer endnuProgressionsfri overlevelse
-
Zhejiang Cancer HospitalRekrutteringStråling | ToripalimabKina
-
Zhejiang Cancer HospitalRekrutteringAvanceret nasopharyngealt karcinomKina
-
Zhejiang Cancer HospitalRekruttering
-
Zhejiang Cancer HospitalRekruttering
-
Zhejiang Cancer HospitalRekrutteringNasopharyngealt karcinomKina
-
Zhejiang Cancer HospitalIkke rekrutterer endnuUterine cervikale neoplasmer | Onkolytisk viroterapi | CamrelizumabKina
-
Zhejiang Cancer HospitalRekrutteringKolorektal cancer metastatisk | Mikrosatellit stabil | Mismatch ReparationsdygtigKina
-
Zhejiang Cancer HospitalRekruttering
-
Zhejiang Cancer HospitalRekruttering
-
Zhejiang Cancer HospitalRekrutteringLivmoderhalskræftKina
-
Zhejiang Cancer HospitalIkke rekrutterer endnuSmåcellet lungekræft omfattende stadie
-
Zhejiang Cancer HospitalIkke rekrutterer endnuMavekræft, HIPEC, Anti-PD-1 antistof Camrelizumab (SHR-1210), kemoterapi og kirurgiKina
-
Zhejiang Cancer HospitalIkke rekrutterer endnuKemoterapi effekt | Gråzone lymfom | Tilbagefald/Gentagelse
-
Zhejiang Cancer HospitalIkke rekrutterer endnu
-
Zhejiang Cancer HospitalIkke rekrutterer endnuLokalt avanceret endetarmskræftKina
-
Zhejiang Cancer HospitalIkke rekrutterer endnu
-
Zhejiang Cancer HospitalIkke rekrutterer endnuIkke-operable trin III NSCLC
-
Zhejiang Cancer HospitalRekrutteringGastrisk AdenocarcinomKina